Special issue commentary: The changing face of inflammation in the brain

[1]  S. Allan,et al.  Systemic immune activation shapes stroke outcome , 2013, Molecular and Cellular Neuroscience.

[2]  F. Geissmann,et al.  Development and homeostasis of “resident” myeloid cells: The case of the microglia , 2013, Glia.

[3]  Richard E. Carson,et al.  Endotoxin-induced systemic inflammation activates microglia: [11C]PBR28 positron emission tomography in nonhuman primates , 2012, NeuroImage.

[4]  D. O'Leary,et al.  TLR-4 Signalling Accelerates Colon Cancer Cell Adhesion via NF-κB Mediated Transcriptional Up-Regulation of Nox-1 , 2012, PloS one.

[5]  Perry Vh.  Innate Inflammation in Parkinson’s Disease , 2012 .

[6]  P. Matthews,et al.  Increased PK11195 PET binding in the cortex of patients with MS correlates with disability , 2012, Neurology.

[7]  V. Camus,et al.  Is unpredictable chronic mild stress (UCMS) a reliable model to study depression-induced neuroinflammation? , 2012, Behavioural Brain Research.

[8]  Anton P. McCaffrey,et al.  Identifying Functional MicroRNAs in Macrophages with Polarized Phenotypes* , 2012, The Journal of Biological Chemistry.

[9]  C. Barcia,et al.  Inflammation and Parkinson's Disease , 2011, Parkinson's disease.

[10]  N. Sibson,et al.  The acute inflammatory response to intranigral α-synuclein differs significantly from intranigral lipopolysaccharide and is exacerbated by peripheral inflammation , 2011, Journal of Neuroinflammation.

[11]  Anastasiya G. Trenova,et al.  Clinical and laboratory study of pro-inflammatory and anti-inflammatory cytokines in women with multiple sclerosis , 2011 .

[12]  B. Sharrack,et al.  Central inflammation versus peripheral regulation in multiple sclerosis , 2011, Journal of Neurology.

[13]  H. Boddeke,et al.  Microglia phenotype diversity. , 2011, CNS & neurological disorders drug targets.

[14]  J. Michálek,et al.  Imbalance in T-cell and cytokine profiles in patients with relapsing-remitting multiple sclerosis , 2011, Journal of the Neurological Sciences.

[15]  M. Biran,et al.  Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration , 2011, Multiple sclerosis.

[16]  F. Ginhoux,et al.  Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages , 2010, Science.

[17]  M. Komada,et al.  Activated Microglia Mediate Axoglial Disruption That Contributes to Axonal Injury in Multiple Sclerosis , 2010, Journal of neuropathology and experimental neurology.

[18]  J. Relton,et al.  Sickness behaviour is induced by a peripheral CXC-chemokine also expressed in Multiple Sclerosis and EAE , 2010, Brain, Behavior, and Immunity.

[19]  B. Felding-Habermann,et al.  Capturing changes in the brain microenvironment during initial steps of breast cancer brain metastasis. , 2010, The American journal of pathology.

[20]  J. M. Aerts,et al.  Differential expression of the EGF-TM7 family members CD97 and EMR2 in lipid-laden macrophages in atherosclerosis, multiple sclerosis and Gaucher disease. , 2010, Immunology letters.

[21]  G. Thwaites,et al.  Update on tuberculosis of the central nervous system: pathogenesis, diagnosis, and treatment. , 2009, Clinics in chest medicine.

[22]  Jessica K. Alexander,et al.  Identification of Two Distinct Macrophage Subsets with Divergent Effects Causing either Neurotoxicity or Regeneration in the Injured Mouse Spinal Cord , 2009, The Journal of Neuroscience.

[23]  C. Carman.  Mechanisms for transcellular diapedesis: probing and pathfinding by `invadosome-like protrusions' , 2009, Journal of Cell Science.

[24]  W. Schulz-Schaeffer,et al.  Screening of innate immune receptors in neurodegenerative diseases: A similar pattern , 2009, Neurobiology of Aging.

[25]  S. Campbell,et al.  Inhibition of peripheral TNF can block the malaise associated with CNS inflammatory diseases , 2008, Neurobiology of Disease.

[26]  R. Keep,et al.  Brain Endothelial Cell-Cell Junctions: How to “Open” the Blood Brain Barrier , 2008, Current neuropharmacology.

[27]  V. Perry,et al.  Systemic inflammation switches the inflammatory cytokine profile in CNS Wallerian degeneration , 2008, Neurobiology of Disease.

[28]  V. Perry,et al.  MRI and MRS alterations in the preclinical phase of murine prion disease: Association with neuropathological and behavioural changes , 2007, Neurobiology of Disease.

[29]  B. McColl,et al.  Systemic Inflammatory Stimulus Potentiates the Acute Phase and CXC Chemokine Responses to Experimental Stroke and Exacerbates Brain Damage via Interleukin-1- and Neutrophil-Dependent Mechanisms , 2007, The Journal of Neuroscience.

[30]  Colm Cunningham,et al.  Systemic infections and inflammation affect chronic neurodegeneration , 2007, Nature Reviews Immunology.

[31]  Alberto Mantovani,et al.  Transcriptional Profiling of the Human Monocyte-to-Macrophage Differentiation and Polarization: New Molecules and Patterns of Gene Expression1 , 2006, The Journal of Immunology.

[32]  S. Mckercher,et al.  Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis , 2006, Proceedings of the National Academy of Sciences.

[33]  A. Depino.  Maternal Infection and the Offspring Brain , 2006, The Journal of Neuroscience.

[34]  R. Malenka,et al.  Synaptic scaling mediated by glial TNF-α , 2006, Nature.

[35]  S. Campbell,et al.  Post‐conditioning with lipopolysaccharide reduces the inflammatory infiltrate to the injured brain and spinal cord: a potential neuroprotective treatment , 2005, The European journal of neuroscience.

[36]  V. Perry,et al.  Central and Systemic Endotoxin Challenges Exacerbate the Local Inflammatory Response and Increase Neuronal Death during Chronic Neurodegeneration , 2005, The Journal of Neuroscience.

[37]  R. Veerhuis,et al.  How chronic inflammation can affect the brain and support the development of Alzheimer's disease in old age: the role of microglia and astrocytes , 2004, Aging cell.

[38]  V. Perry,et al.  Recruitment of Neutrophils across the Blood–Brain Barrier: The Role of E- and P-selectins , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[39]  G. Rook.  Th1- or Th2-cell commitment during infectious disease: an oversimplification? , 2001, Trends in immunology.

[40]  V. Perry,et al.  Absence of Detectable IL‐1β Production in Murine Prion Disease: A Model of Chronic Neurodegeneration , 2001, Journal of neuropathology and experimental neurology.

[41]  L. Minghetti,et al.  Cyclooxygenase‐2 is highly expressed in microglial‐like cells in a murine model of prion disease , 2000, Glia.

[42]  V. Perry,et al.  Loss of the tight junction proteins occludin and zonula occludens-1 from cerebral vascular endothelium during neutrophil-induced blood–brain barrier breakdown in vivo , 1998, Neuroscience.

[43]  R. Zhai,et al.  Microglia and astroglia have a common progenitor cell , 1997, Journal of neuroscience research.

[44]  V. Perry,et al.  EVIDENCE FOR AN EARLY INFLAMMATORY RESPONSE IN THE CENTRAL NERVOUS SYSTEM OF MICE WITH SCRAPIE , 1996, Neuroscience.

[45]  G. Opdenakker,et al.  Cytokines and proteases in invasive processes: molecular similarities between inflammation and cancer. , 1992, Cytokine.

[46]  V. Perry,et al.  The kinetics and morphological characteristics of the macrophage-microglial response to kainic acid-induced neuronal degeneration , 1991, Neuroscience.

[47]  W. Sibley,et al.  CLINICAL VIRAL INFECTIONS AND MULTIPLE SCLEROSIS , 1985, The Lancet.

[48]  C HISCOCK,et al.  YELLOW NAILS AND LYMPHOEDEMA. , 1964, Lancet.

[49]  T. Rivers,et al.  ENCEPHALOMYELITIS ACCOMPANIED BY MYELIN DESTRUCTION EXPERIMENTALLY PRODUCED IN MONKEYS , 1935, The Journal of experimental medicine.

[50]  T. Wyss-Coray,et al.  Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature. , 2012, Cold Spring Harbor perspectives in medicine.

[51]  B. Bogerts,et al.  Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide. , 2008, Journal of psychiatric research.